Advertisement
CTOR vs IMCC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a StrongBuy and IMCC is a Hold.
CTOR's RSI Oscillator ascending out of oversold territory
The RSI Indicator for CTOR moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 13 of the 13 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CTOR just turned positive on November 10, 2026. Looking at past instances where CTOR's MACD turned positive, the stock continued to rise in 18 of 36 cases over the following month. The odds of a continued upward trend are 50%.
Following a +10.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTOR advanced for three days, in 93 of 117 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
CTOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
CTOR moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTOR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The 50-day moving average for CTOR moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CTOR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.334) is normal, around the industry mean (6.379). P/E Ratio (-1.061) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (12.547) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. CTOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
IMCC in -4.08% downward trend, sliding for three consecutive days on November 10, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IMCC declined for three days, in 376 of 401 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for IMCC entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IMCC's RSI Oscillator exited the oversold zone, 40 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
Following a +6.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMCC advanced for three days, in 162 of 192 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IMCC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.070) is normal, around the industry mean (6.379). P/E Ratio (-0.006) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.011) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. IMCC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
IMCC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 26 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 97 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CTOR | IMCC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | N/A | N/A |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 2 days ago 50% | N/A |
| TrendWeek ODDS (%) | 2 days ago 48% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 79% | 14 days ago 84% |
| Declines ODDS (%) | 7 days ago 88% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CTOR’s FA Score shows that 1 FA rating(s) are green while IMCC’s FA Score has 1 green FA rating(s).
- CTOR’s FA Score: 1 green, 4 red.
- IMCC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CTOR’s TA Score shows that 4 TA indicator(s) are bullish while IMCC’s TA Score has 3 bullish TA indicator(s).
- CTOR’s TA Score: 4 bullish, 5 bearish.
- IMCC’s TA Score: 3 bullish, 2 bearish.
Price Growth
CTOR (@Pharmaceuticals: Generic) experienced а +2.31% price change this week, while IMCC (@Pharmaceuticals: Generic) price change was -15.50% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
CTOR is expected to report earnings on Dec 22, 2026.
IMCC is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
CTOR and
Correlation & Price change
A.I.dvisor tells us that CTOR and BFRI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and BFRI's prices will move in lockstep.
| Ticker / NAME | Correlation To CTOR | 1D Price Change % | ||
|---|---|---|---|---|
| CTOR | 100% | +2.40% | ||
| BFRI - CTOR | 25% Poorly correlated | +4.56% | ||
| PRGO - CTOR | 25% Poorly correlated | -0.71% | ||
| IMCC - CTOR | 22% Poorly correlated | -2.31% | ||
| RDHL - CTOR | 21% Poorly correlated | -5.04% | ||
| HIMS - CTOR | 21% Poorly correlated | -16.61% | ||
More | ||||
IMCC and
Correlation & Price change
A.I.dvisor tells us that IMCC and TXMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and TXMD's prices will move in lockstep.
| Ticker / NAME | Correlation To IMCC | 1D Price Change % | ||
|---|---|---|---|---|
| IMCC | 100% | -2.31% | ||
| TXMD - IMCC | 25% Poorly correlated | +2.96% | ||
| ACB - IMCC | 24% Poorly correlated | -0.97% | ||
| SCYX - IMCC | 22% Poorly correlated | +0.57% | ||
| CTOR - IMCC | 22% Poorly correlated | +2.40% | ||
| SNDL - IMCC | 22% Poorly correlated | -0.71% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ETW | 9.48 | -0.03 | -0.32% |
| Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
| RMCA | 23.57 | -0.09 | -0.36% |
| Rockefeller California Municipal Bond ETF (RMCA) | |||
| BBIB | 95.01 | -0.85 | -0.88% |
| JPMorgan BetaBuilders U.S. Treasury Bond 3-10 Year ETF (BBIB) | |||
| TPIF | 37.58 | -0.36 | -0.94% |
| Timothy Plan International ETF (TPIF) | |||
| VELL | 0.68 | -0.03 | -4.51% |
| Defiance Daily Target 2X Long VELO ETF (VELL) | |||